Skip to main content

HCPCS Level II

HCPCS Level II 2009 code changes

Every HCPCS Level II code whose CMS add date or termination date falls in 2009, grouped by effective date. Each code's own page carries its full record.

121
Added
0
Deleted

For HCPCS Level II, MedCoder records each code's CMS add date and termination date from the alpha-numeric file. A deletion is listed on the first day the code is no longer valid (the day after its CMS termination date). Description revisions between quarterly files are not recorded as changes.

Added effective January 1, 2009 (103)

  • A6545 — Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a surgical dressing, each
  • A9284 — Spirometer, non-electronic, includes all accessories
  • A9580 — Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries
  • C8929 — Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
  • C8930 — Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
  • C9248 — Injection, clevidipine butyrate, 1 mg
  • C9899 — Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage
  • E0487 — Spirometer, electronic, includes all accessories
  • E0656 — Segmental pneumatic appliance for use with pneumatic compressor, trunk
  • E0657 — Segmental pneumatic appliance for use with pneumatic compressor, chest
  • E0770 — Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified
  • E1354 — Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each
  • E1356 — Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each
  • E1357 — Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each
  • E1358 — Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each
  • E2230 — Manual wheelchair accessory, manual standing system
  • E2231 — Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware
  • E2295 — Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features
  • G0402 — Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
  • G0403 — Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report
  • G0404 — Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination
  • G0405 — Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination
  • G0406 — Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth
  • G0407 — Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth
  • G0408 — Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth
  • G0409 — Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)
  • G0410 — Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes
  • G0411 — Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes
  • G0412 — Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed
  • G0413 — Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)
  • G0414 — Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)
  • G0415 — Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)
  • G0416 — Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
  • G0417 — Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens
  • G0418 — Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens
  • G0419 — Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens
  • G8489 — I intend to report the coronary artery disease (cad) measures group
  • G8490 — I intend to report the rheumatoid arthritis (ra) measures group
  • G8491 — I intend to report the hiv/aids measures group
  • G8492 — I intend to report the perioperative care measures group
  • G8493 — I intend to report the back pain measures group
  • G8494 — All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient
  • G8495 — All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient
  • G8496 — All quality actions for the applicable measures in the preventive care measures group have been performed for this patient
  • G8497 — All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient
  • G8498 — All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient
  • G8499 — All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient
  • G8500 — All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient
  • G8501 — All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient
  • G8502 — All quality actions for the applicable measures in the back pain measures group have been performed for this patient
  • G8506 — Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
  • G8509 — Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given
  • G8510 — Screening for depression is documented as negative, a follow-up plan is not required
  • G8511 — Screening for depression documented as positive, follow-up plan not documented, reason not given
  • G8530 — Autogenous av fistula received
  • G8531 — Clinician documented that patient was not an eligible candidate for autogenous av fistula
  • G8532 — Clinician documented that patient received vascular access other than autogenous av fistula, reason not given
  • G8535 — Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status
  • G8536 — No documentation of an elder maltreatment screen, reason not given
  • G8539 — Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment
  • G8540 — Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter
  • G8541 — Functional outcome assessment using a standardized tool not documented, reason not given
  • G8542 — Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required
  • G8543 — Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given
  • G8544 — I intend to report the coronary artery bypass graft (cabg) measures group
  • J0641 — Injection, levoleucovorin, not otherwise specified, 0.5 mg
  • J1267 — Injection, doripenem, 10 mg
  • J1453 — Injection, fosaprepitant, 1 mg
  • J1459 — Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1930 — Injection, lanreotide, 1 mg
  • J1953 — Injection, levetiracetam, 10 mg
  • J2785 — Injection, regadenoson, 0.1 mg
  • J3101 — Injection, tenecteplase, 1 mg
  • J3300 — Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
  • J7186 — Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
  • J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
  • J8705 — Topotecan, oral, 0.25 mg
  • J9033 — Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
  • J9207 — Injection, ixabepilone, 1 mg
  • J9330 — Injection, temsirolimus, 1 mg
  • L0113 — Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment
  • L6711 — Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric
  • L6712 — Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric
  • L6713 — Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric
  • L6714 — Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric
  • L6721 — Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined
  • L6722 — Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined
  • L8604 — Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies
  • Q4100 — Skin substitute, not otherwise specified
  • Q4101 — Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4102 — Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4103 — Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4104 — Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4105 — Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4106 — Dermagraft, per square centimeter
  • Q4107 — Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4108 — Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4110 — Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4111 — Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4112 — Cymetra, injectable, 1 cc
  • Q4113 — Graftjacket xpress, injectable, 1 cc
  • Q4114 — Integra flowable wound matrix, injectable, 1 cc
  • S9433 — Medical food nutritionally complete, administered orally, providing 100% of nutritional intake

Added effective April 1, 2009 (5)

  • K0739 — Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes
  • K0740 — Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes
  • S3865 — Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
  • S3866 — Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
  • S3870 — Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability

Added effective July 1, 2009 (8)

  • C9250 — Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
  • C9360 — Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
  • C9361 — Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
  • C9362 — Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
  • C9363 — Skin substitute, integra meshed bilayer wound matrix, per square centimeter
  • C9364 — Porcine implant, permacol, per square centimeter
  • Q4115 — Alloskin, per square centimeter (add-on, list separately in addition to primary procedure)
  • Q4116 — Alloderm, per square centimeter (add-on, list separately in addition to primary procedure)

Added effective August 3, 2009 (1)

  • G9143 — Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

Added effective December 8, 2009 (3)

  • G0432 — Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
  • G0433 — Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
  • G0435 — Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening

Added effective December 23, 2009 (1)

  • G9147 — Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration

Source: CMS HCPCS Level II alpha-numeric file (add and termination dates).

Source data

Source organization
CMS
Source release
HCPCS Level II October 2026 alpha-numeric file
Source file
october-2026-alpha-numeric-hcpcs-file.zip
File checksum (SHA-256)
c25240c63108756d4ba6c0ea785c517117d83bfed9526c51da8acf123de1feb6
Data read date
Data not available in the current MedCoder release record.
Effective date
CMS effective dates within 2009
Release type
Quarterly (January, April, July, October), with occasional mid-quarter additions
Methodology
Each code's add date and termination date are read from the alpha-numeric file. A deletion is dated the first day the code is no longer valid, the day after its termination date. Description revisions are not recorded as changes.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

All releases in the Change Ledger